Maximize Your Impact At ASCO Annual Meeting 2025
ASCO Annual Meeting 2025 is one of the most influential oncology conferences globally, scheduled to take place from May 30 to June 3 at McCormick Place in Chicago, Illinois. This event gathers medical professionals, researchers, healthcare executives, and pharmaceutical leaders who are actively shaping the future of cancer care. With thousands of attendees from around the world, it offers excellent access to decision-makers responsible for clinical trial partnerships, technology adoption, hospital procurement, and policy influence.
For businesses engaged in life sciences, diagnostics, digital health, or healthcare innovation, this conference presents a high-value setting to connect with stakeholders who control research priorities and treatment protocols. From leading oncologists and researchers to innovation officers at top cancer centers, ASCO attendees often arrive at the event ready to form partnerships, assess new technologies, and evaluate vendor solutions. Using an enriched attendee list allows teams to pinpoint strategic accounts early and align outreach with clinical interests or institutional goals.
How Sales and Marketing Teams Can Use This Attendee List
Commercial and field teams can apply the enriched conference attendee list from Vendelux to build high-impact outreach campaigns ahead of ASCO Annual Meeting 2025. Healthcare marketers and medtech sales teams can segment contacts by institution type, whether it’s academic research centers, community hospitals, or biopharma companies. Knowing attendee roles such as director of oncology research or chief medical officer helps teams target clinical trial opportunities, software deployments, or strategic partnerships.
Customized messaging based on each organization’s specialty—such as immunotherapy, rare cancer treatment, or clinical data management—can help secure more pre-scheduled conversations. Outreach should be timed a few weeks ahead of the event, especially toward verified budget holders or department heads. Post-event, teams can use attendee data to frame follow-ups around clinical sessions attended, product discussions that happened onsite, or emerging research interests. The enriched attendee list offers the insight needed to get more meetings, adapt outreach by role or specialty, and convert conference interactions into actionable plans.
Timing Is Everything
ASCO Annual Meeting 2025 runs from May 30 to June 3. Given its size and clinical focus, early outreach is recommended to stand out among vendors and other attendees. Most teams start booking meetings at least four to six weeks in advance, especially when targeting hospital groups or pharmaceutical sponsors. With Vendelux, you can access enriched attendee data early to identify decision-makers and align messaging with what matters to them. This gives your team a major advantage in securing meaningful meetings before schedules fill.
What’s Included In The ASCO Annual Meeting 2025 Attendee List?
The enriched attendee list includes each person’s first and last name, job title, company name, company website, city, state, and country. It also features LinkedIn profiles and, when available, verified email addresses and direct phone numbers, enabling teams to conduct highly targeted outreach before, during, and after the event.
Where Is ASCO Annual Meeting 2025?
ASCO Annual Meeting 2025 is being held at McCormick Place in Chicago, Illinois, United States.
When Is ASCO Annual Meeting 2025?
The event takes place from May 30 to June 3, 2025.
What Type Of Event Is ASCO Annual Meeting 2025?
ASCO Annual Meeting is a global oncology conference focused on the latest research, treatments, and innovation in cancer care. The program includes keynotes, scientific sessions, clinical panels, and partner showcases, with strong opportunities for medical professionals, researchers, and healthcare companies to connect and collaborate.
How Many People Attend ASCO Annual Meeting 2025?
ASCO Annual Meeting 2025 is expected to host over 40,000 attendees from more than 100 countries. The audience includes senior researchers, oncologists, healthcare executives, clinical operations leads, and biopharma partners, representing both academic institutions and global health organizations.
